Compare OPRX & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OPRX | QSI |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 258.2M | 273.7M |
| IPO Year | N/A | N/A |
| Metric | OPRX | QSI |
|---|---|---|
| Price | $12.18 | $1.27 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $19.67 | $2.63 |
| AVG Volume (30 Days) | 241.3K | ★ 5.4M |
| Earning Date | 11-06-2025 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.00 | N/A |
| Revenue | ★ $109,506,000.00 | $3,177,000.00 |
| Revenue This Year | $19.77 | N/A |
| Revenue Next Year | $11.33 | $159.68 |
| P/E Ratio | $6,661.29 | ★ N/A |
| Revenue Growth | 24.18 | ★ 40.20 |
| 52 Week Low | $3.99 | $0.95 |
| 52 Week High | $22.25 | $3.10 |
| Indicator | OPRX | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 39.13 | 48.96 |
| Support Level | $12.23 | $1.18 |
| Resistance Level | $13.00 | $1.32 |
| Average True Range (ATR) | 0.79 | 0.08 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 16.39 | 72.22 |
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.